{"id":"NCT03058666","sponsor":"ONY","briefTitle":"Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients","officialTitle":"Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-03-29","primaryCompletion":"2018-06-01","completion":"2018-07-31","firstPosted":"2017-02-23","resultsPosted":"2024-05-29","lastUpdate":"2024-05-29"},"enrollment":477,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Respiratory Distress Syndrome"],"interventions":[{"type":"DRUG","name":"Aerosolized Calfactant","otherNames":["Infasurf","Calfactant"]},{"type":"DEVICE","name":"Solarys","otherNames":[]}],"arms":[{"label":"Aerosolized Calfactant","type":"EXPERIMENTAL"},{"label":"Usual Care","type":"NO_INTERVENTION"}],"summary":"Study to test the hypothesis that aerosolized Infasurf can decrease the need for intubation and instillation of liquid surfactant to the airway.","primaryOutcome":{"measure":"Intubation and Instillation of Liquid Surfactant","timeFrame":"72 hours","effectByArm":[{"arm":"Aerosolized Calfactant","deltaMin":69,"sd":null},{"arm":"Usual Care","deltaMin":120,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Hour","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":22,"countries":["United States"]},"refs":{"pmids":["33060258"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":241},"commonTop":["Hyperbilirubinemia","Apnea","Anemia","Dysphagia","Hypoglycemia"]}}